Russell E. Bishop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Russell E. Bishop has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
M. Adil Khan
Department of Biochemistry and Biomedical Sciences and Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada L8N 3Z5
4 shared publicationsSang-Hyun Kim
The National Primate Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Cheongwon, Chungbuk 363–883, Republic of Korea
3 shared publicationsEkyune Kim
College of Pharmacy, Catholic University of Daegu, Hayang-eup, Gyeongsan, Gyeongbuk 712-702, Republic of Korea
2 shared publicationsJoel Moktar
Department of Biochemistry and Biomedical Sciences and Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada L8N 3Z5
2 shared publications- Kyu-Tae Chang
National Primate Research Center (NPRC), Korea Research Institute of Bioscience and Biotechnology (KRIBB), Ochang, Korea
2 shared publications Patrick J. Mott
Department of Biochemistry and Biomedical Sciences and Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON, Canada L8N 3Z5
2 shared publications
Latest Publications
- 23 December 2020
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 28 (1) , 8-10
Phospholipid transporter shifts into reverse
- 23 December 2020
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 28 (1) , 8-10
Phospholipid transporter shifts into reverse
- 1 August 2020
- Published by Elsevier in Journal of Molecular Biology
- Vol. 432 (18) , 4943-4945
Integral Membrane Enzymes (2020)
- 1 August 2020
- Published by Elsevier in Journal of Molecular Biology
- Vol. 432 (18) , 4943-4945
Integral Membrane Enzymes (2020)
- 20 September 2019
- Published by Springer Nature in Nature Microbiology
- Vol. 4 (10) , 1608-1609
Phospholipid middle management
- 20 September 2019
- Published by Springer Nature in Nature Microbiology
- Vol. 4 (10) , 1608-1609
Phospholipid middle management
- 9 January 2019
- Published by Springer Nature
- p. 151-162
Lipid A
- 1 November 2017
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1862 (11) , 1285-1286
Bacterial lipids
- 1 November 2017
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1862 (11) , 1285-1286
Bacterial lipids
- Open Access
- 30 December 2016
- Published by American Society for Microbiology in mBio
- Vol. 7 (6) , e01903-16
Polymorphic Regulation of Outer Membrane Lipid A Composition
The importance of the polymorphic-phase behavior of lipid A structural variations in determining their endotoxic activities has been recognized previously, but any potential role for lipid A polymorphism in controlling outer membrane structure and function has been largely ignored until now. In a recent article in mBio [7(5):e01532-16, https://doi.org/10.1128/mBio.01532-16], Katherine E. Bonnington and Meta J. Kuehn of Duke University’s Department of Biochemistry make a compelling case for considering how the molecular shapes of the various lipid A structural subtypes found in the outer membrane contribute to the process of outer membrane vesicle (OMV) formation.
- 30 December 2016
- Published by American Society for Microbiology in mBio
- Vol. 7 (6) , e01903-16
Open AccessPolymorphic Regulation of Outer Membrane Lipid A Composition
The importance of the polymorphic-phase behavior of lipid A structural variations in determining their endotoxic activities has been recognized previously, but any potential role for lipid A polymorphism in controlling outer membrane structure and function has been largely ignored until now. In a recent article in mBio [7(5):e01532-16, https://doi.org/10.1128/mBio.01532-16], Katherine E. Bonnington and Meta J. Kuehn of Duke University’s Department of Biochemistry make a compelling case for considering how the molecular shapes of the various lipid A structural subtypes found in the outer membrane contribute to the process of outer membrane vesicle (OMV) formation.
- 1 January 2016
- Published by Springer Nature
- p. 1-12
Lipid A
- Open Access
- 15 September 2014
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 196 (18) , 3209-3213
Emerging Roles for Anionic Non-Bilayer Phospholipids in Fortifying the Outer Membrane Permeability Barrier
Lately, researchers have been actively investigating Escherichia coli lptD mutants, which exhibit reduced transport of lipopolysaccharide to the cell surface. In this issue of the Journal of Bacteriology , Sutterlin et al. ( H. A. Sutterlin, S. Zhang, and T. J. Silhavy, J. Bacteriol. 196:3214–3220 , 2014) now reveal an important functional role for phosphatidic acid in fortifying the outer membrane permeability barrier in certain lptD mutant backgrounds. These findings come on the heels of the first reports of two LptD crystal structures, which now provide a structural framework for interpreting lptD genetics.
- 15 September 2014
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 196 (18) , 3209-3213
Open AccessEmerging Roles for Anionic Non-Bilayer Phospholipids in Fortifying the Outer Membrane Permeability Barrier
Lately, researchers have been actively investigating Escherichia coli lptD mutants, which exhibit reduced transport of lipopolysaccharide to the cell surface. In this issue of the Journal of Bacteriology , Sutterlin et al. ( H. A. Sutterlin, S. Zhang, and T. J. Silhavy, J. Bacteriol. 196:3214–3220 , 2014) now reveal an important functional role for phosphatidic acid in fortifying the outer membrane permeability barrier in certain lptD mutant backgrounds. These findings come on the heels of the first reports of two LptD crystal structures, which now provide a structural framework for interpreting lptD genetics.
- Open Access
- 18 June 2014
- Published by Springer Nature in Nature
- Vol. 511 (7507) , 37-38
Lipopolysaccharide rolls out the barrel
Two crystal structures of the LptD–LptE protein complex reveal how the cell-wall component lipopolysaccharide is delivered and inserted into the external leaflet of the bacterial outer membrane. See Article p.52 & Letter p.108
- 18 June 2014
- Published by Springer Nature in Nature
- Vol. 511 (7507) , 37-38
Open AccessLipopolysaccharide rolls out the barrel
Two crystal structures of the LptD–LptE protein complex reveal how the cell-wall component lipopolysaccharide is delivered and inserted into the external leaflet of the bacterial outer membrane. See Article p.52 & Letter p.108
- Open Access
- 6 November 2013
- Published by Wiley in Molecular Microbiology
- Vol. 91 (1) , 158-174
A divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis‐specific lipid A
Summary: Strains of Pseudomonas aeruginosa (PA) isolated from the airways of cystic fibrosis patients constitutively add palmitate to lipid A, the membrane anchor of lipopolysaccharide. The PhoPQ regulated enzyme PagP is responsible for the transfer of palmitate from outer membrane phospholipids to lipid A. This enzyme had previously been identified in many pathogenic Gram‐negative bacteria, but in PA had remained elusive, despite abundant evidence that its lipid A contains palmitate. Using a combined genetic and biochemical approach, we identified PA1343 as the PA gene encoding PagP. Although PA1343 lacks obvious primary structural similarity with known PagP enzymes, the β‐barrel tertiary structure with an interior hydrocarbon ruler appears to be conserved. PA PagP transfers palmitate to the 3′ position of lipid A, in contrast to the 2 position seen with the enterobacterial PagP. Palmitoylated PA lipid A alters host innate immune responses, including increased resistance to some antimicrobial peptides and an elevated pro‐inflammatory response, consistent with the synthesis of a hexa‐acylated structure preferentially recognized by the TLR4/MD2 complex. Palmitoylation commonly confers resistance to cationic antimicrobial peptides, however, increased cytokine production resulting in inflammation is not seen with other palmitoylated lipid A, indicating a unique role for this modification in PA pathogenesis.
- 6 November 2013
- Published by Wiley in Molecular Microbiology
- Vol. 91 (1) , 158-174
Open AccessA divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis‐specific lipid A
Summary: Strains of Pseudomonas aeruginosa (PA) isolated from the airways of cystic fibrosis patients constitutively add palmitate to lipid A, the membrane anchor of lipopolysaccharide. The PhoPQ regulated enzyme PagP is responsible for the transfer of palmitate from outer membrane phospholipids to lipid A. This enzyme had previously been identified in many pathogenic Gram‐negative bacteria, but in PA had remained elusive, despite abundant evidence that its lipid A contains palmitate. Using a combined genetic and biochemical approach, we identified PA1343 as the PA gene encoding PagP. Although PA1343 lacks obvious primary structural similarity with known PagP enzymes, the β‐barrel tertiary structure with an interior hydrocarbon ruler appears to be conserved. PA PagP transfers palmitate to the 3′ position of lipid A, in contrast to the 2 position seen with the enterobacterial PagP. Palmitoylated PA lipid A alters host innate immune responses, including increased resistance to some antimicrobial peptides and an elevated pro‐inflammatory response, consistent with the synthesis of a hexa‐acylated structure preferentially recognized by the TLR4/MD2 complex. Palmitoylation commonly confers resistance to cationic antimicrobial peptides, however, increased cytokine production resulting in inflammation is not seen with other palmitoylated lipid A, indicating a unique role for this modification in PA pathogenesis.